Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.27 USD | +2.19% |
|
+9.73% | +7.21% |
Jul. 01 | Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics | MT |
May. 30 | Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CODEXIS, INC. | Other Biotechnology & Medical Research | +2.19% | +9.73% | +7.21% | +4.14% | -82.54% | 231M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- CDXS Stock
- Charts Codexis, Inc.
- Relative Strength Chart